RESUMO
There is an increased demand for gender affirmation surgery. Chest contouring, or "top" surgery, is especially important in the female-to-male (FtM) transgender population. This Continuing Medical Education (CME) article critically appraises the available literature on top surgery to allow plastic surgeons to understand current practices and determine the best surgical technique using a decision algorithm and the patient's preoperative anatomy and characteristics. Because a single best surgical approach does not exist due to significant variance in preoperative patient anatomy, and in order to provide a useful framework for decision making, surgical approaches described are categorized as: approach 1-remote incision procedures without skin excision; approach 2-procedures with periareolar skin excision; and approach 3-mastectomy procedures with skin excision other than periareolar skin excision. Decision algorithms that help determine the most suitable surgical technique for individual patients are reviewed. Data on complication rates and patient satisfaction will improve informed consent discussions and create realistic patient expectations.
Assuntos
Disforia de Gênero/cirurgia , Mamoplastia/métodos , Mastectomia/métodos , Cirurgia de Readequação Sexual/métodos , Pessoas Transgênero , Tomada de Decisão Clínica , Feminino , Humanos , Consentimento Livre e Esclarecido , Masculino , Mamoplastia/legislação & jurisprudência , Mastectomia/legislação & jurisprudência , Satisfação do Paciente , Cirurgia de Readequação Sexual/legislação & jurisprudênciaRESUMO
IMPORTANCE: With the stabilization of breast cancer incidence and substantial improvement in survival, more attention has focused on postmastectomy breast reconstruction (PBR). Despite its demonstrated benefits, wide disparities in the use of PBR remain. Physician-patient communication has an important role in disparities in health care, especially for elective surgical procedures. Recognizing this, the State of New York enacted Public Health Law (NY PBH Law) 2803-o in 2011 mandating that physicians communicate about reconstructive surgery with patients undergoing mastectomy. OBJECTIVE: To evaluate whether mandated physician-patient communication is associated with reduced racial/ethnic disparities in immediate PBR (IPBR). DESIGN, SETTING, AND PARTICIPANTS: This retrospective study used state inpatient data from January 1, 2008, through December 31, 2011, in New York and California to evaluate a final sample of 42â¯346 women aged 20 to 70 years, including 19â¯364 from New York (treatment group) and 22â¯982 from California (comparison group). The primary hypothesis tested the effect of the New York law on racial/ethnic disparities, using California as a comparator. The National Academy of Medicine's (formerly Institute of Medicine) definition of a disparity was applied, and a difference-in-differences method (before-and-after comparison design) was used to evaluate the association of NY PBH Law 2803-o mandating physician-patient communication with disparities in IPBR. Data were analyzed from July 1, 2016, to February 24, 2017. EXPOSURES: New York PBH Law 2803-o was implemented on January 1, 2011. The preexposure period included January 1, 2008, through December 31, 2010 (3 years); the postexposure period, January 1 through December 31, 2011 (1 year). MAIN OUTCOMES AND MEASURES: The primary outcome was use of IPBR among white, African American, Hispanic, and other minority groups before and after the implementation of NY PBH Law 2803-o. RESULTS: Among the 42â¯346 women (mean [SD] age, 53 [10] years), 65.3% (27â¯654) were white, 12.7% (5365) were Hispanic, 9.4% (3976) were African American, and 12.6% (5351) were other minorities. The new legislation was not associated with the overall IPBR rate or disparity in IPBR between whites and African Americans (reduction of 1 percentage point; 95% CI, -0.02 to 0.04), but it was associated with a reduction in disparities in IPBR between Hispanic and white patients by 9 (95% CI, 0.06-0.11) percentage points and between other minorities and white patients by 13 (95% CI, 0.11-0.16) percentage points. CONCLUSIONS AND RELEVANCE: Physician-patient communication may help to address inequity in the use of elective surgical procedures, such as IPBR. However, lack of patient trust and/or effective physician-patient communication may reduce the potential effect of mandatory communication for some subpopulations, including African American individuals.
Assuntos
Neoplasias da Mama/cirurgia , Disparidades em Assistência à Saúde/legislação & jurisprudência , Mamoplastia/legislação & jurisprudência , Mastectomia/legislação & jurisprudência , Relações Médico-Paciente , Negro ou Afro-Americano , Comunicação , Feminino , Política de Saúde , Hispânico ou Latino , Humanos , Pessoa de Meia-Idade , New York , Aceitação pelo Paciente de Cuidados de SaúdeAssuntos
Neoplasias da Mama/cirurgia , Cobertura do Seguro/legislação & jurisprudência , Seguro Saúde/legislação & jurisprudência , Mamoplastia/legislação & jurisprudência , Mastectomia/legislação & jurisprudência , Direitos do Paciente/legislação & jurisprudência , Neoplasias da Mama/economia , Feminino , Humanos , Mamoplastia/economia , Mastectomia Segmentar/legislação & jurisprudência , Estados UnidosAssuntos
Neoplasias da Mama/cirurgia , Responsabilidade Legal , Imperícia/legislação & jurisprudência , Mastectomia/legislação & jurisprudência , Inabilitação do Médico/legislação & jurisprudência , Inglaterra , Feminino , Humanos , Imperícia/economia , Inabilitação do Médico/psicologia , Medicina Estatal , Procedimentos DesnecessáriosAssuntos
Estatura , Tomada de Decisões/ética , Deficiências do Desenvolvimento/complicações , Pessoas com Deficiência , Deficiência Intelectual/complicações , Pais , Puberdade Precoce/terapia , Qualidade de Vida , Esterilização Involuntária/ética , Esterilização Involuntária/legislação & jurisprudência , Argumento Refutável , Estatura/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Criança , Defesa da Criança e do Adolescente , Comportamento de Escolha/ética , Estrogênios/administração & dosagem , Comissão de Ética , Ética Clínica , Feminino , Hospitais Pediátricos/ética , Humanos , Histerectomia/ética , Histerectomia/legislação & jurisprudência , Mastectomia/ética , Mastectomia/legislação & jurisprudência , Autonomia Pessoal , Pessoalidade , Prognóstico , Puberdade Precoce/complicações , Puberdade Precoce/tratamento farmacológico , Puberdade Precoce/cirurgia , Terminologia como Assunto , IncertezaRESUMO
In 2006, a paper in the journal Archives of Pediatric and Adolescent Medicine described a novel case of growth attenuation therapy and other treatments carried out on Ashley, a severely cognitively, neurologically and physically disabled 6-year-old girl. Some of the moral arguments that have sprung up in respect of the so-called "Ashley treatment" are considered, and it is suggested that they all miss something-that the proper treatment of Ashley may have as much to do with doctors' duties to themselves as with their duties to her. It is suggested that the Ashley treatment may have been in violation of doctors' self-regarding duties and that this possibility is worthy of further investigation.
Assuntos
Temas Bioéticos , Tamanho Corporal/efeitos dos fármacos , Tomada de Decisões/ética , Mastectomia/ética , Consentimento dos Pais/ética , Esterilização Involuntária/ética , Criança , Deficiências do Desenvolvimento , Crianças com Deficiência , Ética Médica , Feminino , Humanos , Mastectomia/legislação & jurisprudência , Obrigações Morais , Consentimento dos Pais/legislação & jurisprudência , Pais/psicologia , Defesa do Paciente/ética , Pessoas com Deficiência Mental , Qualidade de Vida/psicologia , Esterilização Involuntária/legislação & jurisprudênciaRESUMO
This Note discusses the recent controversy surrounding a six-year-old girl named Ashley, whose parents chose to purposefully stunt her growth and remove her reproductive organs for nonmedical reasons. A federal investigation determined that Ashley's rights had been violated because doctors performed the procedure, now referred to as the "Ashley Treatment," without first obtaining a court order. However, the investigation did not make any conclusions regarding whether the "Ashley Treatment" could present a legally permissible treatment option in the future. After discussing the constitutional rights that the "Ashley Treatment" implicates and the current legal standards in place, this Note examines how courts have applied these legal standards to cases involving extreme requests. Drawing upon legal commentators, this Note concludes that a court could approve a request for the "Ashley Treatment" in appropriate and limited cases where the parents have presented clear and convincing evidence before a court that the benefits that the "Ashley Treatment" would provide to the child and her family outweigh the risks associated with the procedure. This Note argues that those benefits may include extrinsic considerations, but courts should remain cautious when considering such evidence and be sure that the evidence as a whole supports their conclusions.